Cardiovascular Systems Inc (CSII) - Product Pipeline Analysis, 2023 Update

Summary


Cardiovascular Systems Inc (CSI), a subsidiary of Abbott Laboratories, is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy systems, coronary orbital atherectomy systems, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems technology for both peripheral and coronary commercial applications. The company serves patients suffering from peripheral arterial disease and coronary artery diseases. It markets its products through its network of distributors in the US to hospitals and clinics. CSI is headquartered in St. Paul, Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Cardiovascular Systems Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


Cardiovascular Systems Inc Company Overview
Cardiovascular Systems Inc Company Snapshot
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Cardiovascular Systems Inc – Pipeline Analysis Overview
Cardiovascular Systems Inc - Key Facts
Cardiovascular Systems Inc - Major Products and Services
Cardiovascular Systems Inc Pipeline Products by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc Pipeline Products Overview
Antegrade/Retrograde Microcatheter
Antegrade/Retrograde Microcatheter Product Overview
Chronic Total Occlusion Catheter
Chronic Total Occlusion Catheter Product Overview
Complex Percutaneous Coronary Intervention Catheter
Complex Percutaneous Coronary Intervention Catheter Product Overview
cPCI Hemodynamic Support System
cPCI Hemodynamic Support System Product Overview
Fourth Generation Diamondback 360 Orbital Atherectomy System
Fourth Generation Diamondback 360 Orbital Atherectomy System Product Overview
Guide Extension Catheter
Guide Extension Catheter Product Overview
IVL System
IVL System Product Overview
Laser Atherectomy Device
Laser Atherectomy Device Product Overview
MCS System
MCS System Product Overview
Mixed Plaque Atherectomy System
Mixed Plaque Atherectomy System Product Overview
Next Gen Guide Wire
Next Gen Guide Wire Product Overview
Next Gen OAS System - Coronary
Next Gen OAS System - Coronary Product Overview
Next Generation Pump
Next Generation Pump Product Overview
PAD Radial Guidewire
PAD Radial Guidewire Product Overview
Peripheral PTA Balloon Catheter
Peripheral PTA Balloon Catheter Product Overview
Propel
Propel Product Overview
Propel Clinical Trial
Third Generation Diamondback 360 Orbital Atherectomy System
Third Generation Diamondback 360 Orbital Atherectomy System Product Overview
WIRION EPD System - LE Atherectomy
WIRION EPD System - LE Atherectomy Product Overview
ZILIENT Guidewire - Coronary Intervention
ZILIENT Guidewire - Coronary Intervention Product Overview
Cardiovascular Systems Inc - Key Competitors
Cardiovascular Systems Inc - Key Employees
Cardiovascular Systems Inc - Locations And Subsidiaries
Head Office
Recent Developments
Cardiovascular Systems Inc, Recent Developments
Oct 12, 2022: Cardiovascular Systems to Host Earnings Conference Call on November 3, 2022
Feb 24, 2022: Cardiovascular Systems and Innova Vascular partner on thrombectomy devices
Jan 13, 2022: Cardiovascular Systems announces development of intravascular lithotripsy technology for the treatment of coronary and peripheral artery diseases
Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
Feb 03, 2021: Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results
Feb 01, 2021: Cardiovascular Systems announces partnership with Chansu Vascular to develop new drug-coated balloon technology
Oct 21, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2021 First-Quarter Earnings Conference Call Wednesday, November 4
Jul 14, 2020: Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Fourth-Quarter Earnings Conference Call Tuesday, August 4
Dec 16, 2019: Cardiovascular Systems, introduces peripheral orbital atherectomy system with GlideAssist in Europe
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Cardiovascular Systems Inc Pipeline Products and Ongoing Clinical Trials Overview
Cardiovascular Systems Inc Pipeline Products by Equipment Type
Cardiovascular Systems Inc Pipeline Products by Indication
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc, Key Facts
Cardiovascular Systems Inc, Major Products and Services
Cardiovascular Systems Inc Number of Pipeline Products by Development Stage
Cardiovascular Systems Inc Pipeline Products Summary by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status
Cardiovascular Systems Inc Ongoing Clinical Trials Summary
Antegrade/Retrograde Microcatheter - Product Status
Antegrade/Retrograde Microcatheter - Product Description
Chronic Total Occlusion Catheter - Product Status
Chronic Total Occlusion Catheter - Product Description
Complex Percutaneous Coronary Intervention Catheter - Product Status
Complex Percutaneous Coronary Intervention Catheter - Product Description
cPCI Hemodynamic Support System - Product Status
cPCI Hemodynamic Support System - Product Description
Fourth Generation Diamondback 360 Orbital Atherectomy System - Product Status
Fourth Generation Diamondback 360 Orbital Atherectomy System - Product Description
Guide Extension Catheter - Product Status
Guide Extension Catheter - Product Description
IVL System - Product Status
IVL System - Product Description
Laser Atherectomy Device - Product Status
Laser Atherectomy Device - Product Description
MCS System - Product Status
MCS System - Product Description
Mixed Plaque Atherectomy System - Product Status
Mixed Plaque Atherectomy System - Product Description
Next Gen Guide Wire - Product Status
Next Gen Guide Wire - Product Description
Next Gen OAS System - Coronary - Product Status
Next Gen OAS System - Coronary - Product Description
Next Generation Pump - Product Status
Next Generation Pump - Product Description
PAD Radial Guidewire - Product Status
PAD Radial Guidewire - Product Description
Peripheral PTA Balloon Catheter - Product Status
Peripheral PTA Balloon Catheter - Product Description
Propel - Product Status
Propel - Product Description
Propel - Cardiovascular Systems, Inc. (CSI) Percutaneous Ventricular Assist Device (pVAD) Second in Human Study
Third Generation Diamondback 360 Orbital Atherectomy System - Product Status
Third Generation Diamondback 360 Orbital Atherectomy System - Product Description
WIRION EPD System - LE Atherectomy - Product Status
WIRION EPD System - LE Atherectomy - Product Description
ZILIENT Guidewire - Coronary Intervention - Product Status
ZILIENT Guidewire - Coronary Intervention - Product Description
Cardiovascular Systems Inc, Key Employees
Glossary
List of Figures
Cardiovascular Systems Inc Pipeline Products by Equipment Type
Cardiovascular Systems Inc Pipeline Products by Development Stage
Cardiovascular Systems Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings